GEMOX CHEMOTHERAPY

Clinical trials for GEMOX CHEMOTHERAPY explained in plain language.

Never miss a new study

Get alerted when new GEMOX CHEMOTHERAPY trials appear

Sign up with your email to follow new studies for GEMOX CHEMOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Three-Drug attack before surgery aims to stop deadly liver Cancer's return

Disease control Ongoing

This study is testing a new three-drug combination given before surgery for a type of aggressive liver cancer called intrahepatic cholangiocarcinoma. The goal is to shrink tumors and lower the very high chance of the cancer coming back after surgery. Researchers will compare this…

Matched conditions: GEMOX CHEMOTHERAPY

Phase: PHASE2, PHASE3 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control

Last updated Mar 09, 2026 14:23 UTC

GEMOX CHEMOTHERAPY

Get alerted when new GEMOX CHEMOTHERAPY trials appear

Three-Drug attack before surgery aims to stop deadly liver Cancer's return